Menu

Department of Military Affairs Tender by Indian Army (GEM/2025/B/6139176)

MITOMYCIN C 40 MG INJ,Recombinant Human Growth Hormone 5 mg to 15 mg Inj or equivalent in IUs,Caspo

Goods
Qty:10.4K
EMD: ₹544
Department of Military Affairs Tender by Indian Army (GEM/2025/B/6139176)

Tender Timeline

Tender Issue
April 30, 2025 at 1:17 PM

Introduction

This tender, issued by the Department of Military Affairs under the Ministry of Defence, invites qualified suppliers to submit bids for the supply of specialized pharmaceutical products. The primary items required include MITOMYCIN C 40 MG INJ, Recombinant Human Growth Hormone 5 mg to 15 mg Inj, and Caspofungin 50 mg per 10 ml Inj among other essential medications. This procurement aims to cater to the healthcare needs of defense personnel and related medical institutions.

Scope of Work and Objectives

The scope of work encompasses the procurement of a total quantity of 10,356 units of the specified medical products, ensuring they meet stringent quality and compliance standards. The objectives of this tender are to secure reliable suppliers who can deliver these pharmaceutical products in a timely manner, maintaining the highest standards of quality and efficacy.

Eligibility Criteria

To be eligible for this tender, bidders must meet several crucial criteria:

  • Must be a registered legal entity capable of manufacturing or supplying the specified pharmaceuticals.
  • Should have relevant certifications that demonstrate compliance with health and safety regulations.
  • Experience in dealing with defense or governmental healthcare sectors is preferred.

Technical Requirements

  • All products supplied must comply with the applicable Indian pharmacopoeia standards.
  • The pharmaceutical products should come with the required dosages and specifications as outlined in the tender documentation.
  • Quality assurance protocols must be in place, and suppliers should be prepared to submit documentation verifying these standards.

Financial Requirements

Bidders are expected to provide financial details that demonstrate their capacity to fulfill the order. This includes:

  • Bank guarantees or statements proving financial stability.
  • Pricing details for each item, ensuring they fall within the budget constraints set forth by the Department of Military Affairs.

Document Submission Details

Bidders must submit their proposals electronically through the designated e-tendering platform. Each submission should include:

  • Completed bid forms.
  • All requisite certifications and documentation.
  • Technical and financial proposals as specified in the tender requirements.

Special Provisions

  • This tender encourages participation from Micro, Small, and Medium Enterprises (MSEs) and offers benefits to promote inclusivity.
  • Startups may also avail special provisions aimed at fostering innovation and competition within the pharmaceutical supply sector.

Evaluation Process

The evaluation mechanism for this tender will follow a two-stage process:

  1. Technical Evaluation: All bids will be assessed based on their compliance with the technical specifications and eligibility criteria.
  2. Financial Evaluation: Candidates who meet the technical requirements will then have their financial bids evaluated to determine the most cost-effective supplier.

Delivery Locations

The successful bidder will be responsible for delivering the pharmaceutical products to designated military healthcare facilities across various locations as specified in subsequent communication.

Contact Information

For queries or more information regarding this tender, please refer to the official communication channels provided in the tender documentation.


Tender BOQ Items

9 Items
1.

MITOMYCIN C 40 MG INJ

Qty:90
Unit:vial
30
2.

Recombinant Human Growth Hormone 5 mg to 15 mg Inj or equivalent in IUs

Qty:252
Unit:pfs
30
3.

Caspofungin 50 mg per 10 ml Inj in 10 ml vial

Qty:1800
Unit:vial
30
4.

COLISTIMETHATE SODIUM 2 MU per ML INJ

Qty:3384
Unit:vial
30
5.

COLISTIMETHATE SODIUM 1 MU per ML INJ

Qty:3930
Unit:vial
30
6.

INJ INTERFERON BETA 1A 30 MCG 6 MILLION IU 0.5 MI R DNA ORIGIN PREFILLED SYRINGS and PREFILLED PEN AVONEX

Qty:48
Unit:pfs
30
7.

ZOLMITRIPTAN NASAL SPRAY 5MG 7 METERED DOSES

Qty:72
Unit:bott
30
8.

SODIUM PHOSPHATE SOLUTION 45 ML EACH PACK OF 2 BOTTLE

Qty:720
Unit:pack
30
9.

N BUTYL CYANOACRYLATE 0 5ML INJ

Qty:60
Unit:amp vial
30

General Information

Item Category
MITOMYCIN C 40 MG INJ , Recombinant Human Growth Hormone 5 mg to 15 mg Inj or equivalent in IUs , Caspofungin 50 mg per 10 ml Inj in 10 ml vial , COLISTIMETHATE SODIUM 2 MU per ML INJ , COLISTIMETHATE SODIUM 1 MU per ML INJ , INJ INTERFERON BETA 1A 30 MCG 6 MILLION IU 0.5 MI R DNA ORIGIN PREFILLED SYRINGS and PREFILLED PEN AVONEX , ZOLMITRIPTAN NASAL SPRAY 5MG 7 METERED DOSES , SODIUM PHOSPHATE SOLUTION 45 ML EACH PACK OF 2 BOTTLE , N BUTYL CYANOACRYLATE 0 5ML INJ
Ministry Name
Organisation Name
City

Financial Information

EMD Amount
₹544.00
OEM Average Turnover
₹18.00 Lakh (s)
Minimum Turnover
₹18.00 Lakh (s)
Bid Offer Validity
180 (Days)
Past Performance
30 %
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Item wise evaluation/
RA Qualification Rule
H1-Highest Priced Bid Elimination
Inspection Required
Yes
Technical Clarifications Time
3 Days

Tender Documents

4 Documents
GeM-Bidding-7738645.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Past Performance
  • Bidder Turnover
  • Certificate (Requested in ATC)
  • OEM Authorization Certificate
  • OEM Annual Turnover *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Similar Tenders

View All

Inj Adrenaline,Inj Amikacin,Inj Amphoteracin,Inj Aminophylline,Inj Artisunate 60 mg Vial,Inj Atracu

GEM
Goods
Qty:31.5L
6 Files
N/a
CENTRAL DELHI, DELHI
Boq › Boql
Inj Adrenaline , Inj Amikacin , Inj Amphoteracin , Inj Aminophylline , Inj Artisunate 60 mg Vial , Inj Atracurium Besylate , Inj Atropine Sulphate , Inj Ampicillin 500 mg Vial , Inj Amoxy 1 gm with Clavulanic Acid , Inj Anti Rabies Vaccine , Inj Anti Tetanus Vaccine , Inj Amphoteracin B Lipid Complex , Inj Azithromycin 500 mg Vial , Inj Acyclovir 250 mg , Inj Acyclovir 500 mg , Inj Aztreonam 1 gm Vial , Inj Adenosine , Inj Amiodarone , Inj Ascorbic Acid , Inj Amphotericin , Inj Bupivacaine in Dextrose , Inj Bupivacaine , Inj Benzathine Penicillin , Inj Caspofungin 50 mg Vial , Inj Cefepime 1 gm Vial , Inj Cefoperazone 500 mg and Sulbactum 500mg , Inj Cefuroxime Sod. 750 mg Vial , Inj Clindamycin 600 mg per 4 ml Amp , Inj Ceftazidime 1 gm Vial , Inj Cefotaxime 1 gm , Inj Ceftriaxone 1 gm , Inj Calcium Gluconate 100 mg per ml , Inj Colistin Methanosulfonate 1 MIU , Inj Diltiazem 5 mg per ml , Inj Dexmedetomidine 200 mcgper 2 ml , Inj Digoxin 0.25 mg per ml , Inj Dexamethasone 4 mg per 2 ml Vial , Inj Diazepam 5 mg per ml , Inj Diclofenac Sodium 25 mg per ml , Inj Diclofenac Sodium 75 mg per ml , Water for Injection 5 ml Amp , Inj Dopamine Hcl 40 mg per ml , Inj Doxycycline 100 mg Vial , Inj Etophylline 169 mg with Theophylline , Inj Ferric Carboxymaltose 500 mg per 10 ml Vial , Inj Esmolol 10 mg per ml Vial , Inj Enoxaparin 40 mg , Inj Enoxaparin 60 mg , Inj Frusemide 10 mg per ml , Inj Ganciclovir Lyophilised 500 mg Vial , Inj Gentamycin 80 mg per 2 ml , Inj Glycopyrrolate 0.2 mg per ml , Inj Haloperidol 5 mg per ml , Inj Heparin 25000 IUper 5 ml , Inj Hydrocortisone 100 mg Vial , Inj Hyoscine Butyl Bromide 20 mg per ml , Inj Insulin Glargine 100 IUperml , Inj Insulin Mixtard , Inj Insulin NPH Lente , Inj Insulin Plain , Inj Imipenam 500 mg with Cilastatin 500 mg Vial , Inj Isoprenaline 2 mg per ml , Inj Ketamine , Inj L Ornithine L Aspartate , Inj Lignocaine 2 percent 50 ml , Inj Lignocaine 20 mg with Adrenaline , Inj Lignocaine Plain , Inj Labetalol 20 mg per 4 ml , Inj Levetiracetam 500 mlper 5 ml , Inj Methyl Prednisolone Acetate 500 mg Vial , Inj Methyl Prednisolone Acetate 1000 mg Vial , Inj Methyl Prednisolone 40 mg , Inj Metoprolol Tartrate 1 mg per ml , Inj Meropenam 1 gm Vial , Inj Magnessium Sulphate 500 mg per ml , Inj Mephentermine 30 mg per ml , Inj Metaclopramide 5 mg per ml , Inj Methyl Ergometrine , Inj Midazolam 5 mg per ml , Inj Multi Vitamin , In. Noradrenaline 4 mg per ml , Inj Neostigamine 0.5 mg per ml , Inj Nitroglycerine 1 mg per ml , Inj Octreotide 50 mcg Amp , Inj Ondensterone 2 mg per ml , Inj Oxytocin 5 IUper ml , Inj Pantoprazole 40 mg per 10 ml , Inj Phenaramine Maleate , Inj Phenobarbitone 200 mg per ml , Inj Phenytoin Sodium 50 mg per ml , Inj Phenylephrine Hcl 10 mg per ml , Inj Pipracillin 4 gm with Tazobactum , Inj Potassium Chloride 150 mg per 10 ml , Inj Pralidoxime , Inj Promethazine Hcl 25 ml , Inj Propofol 1 percent , Inj Ranitidine 25 mg per ml , Inj Rocuronium Bromide 10 mg per ml , Inj Sodabicarb 7.5 percent , Inj Sodium Valporate 100 mg per 5 ml , Inj Thiopentone Sodium 1 gm Vial , Inj Tiecoplanin 400 mg Vial , Inj Tiecoplanin 200 mg per 3 ml Vial , Inj Tigecycline 50 mg Vial , Inj Tranexanic Acid 100 mg per ml , Inj Thiamine 100 mg per 2 ml , Inj Vacuronium Bromide 4 mg per 2 ml , Inj Vasopressin 20 IU Amp. , Inj Vancomycin 500 mg Vial
April 11, 2025
May 22, 2025 at 4:00 PM
View Details

Adrenaline Tartrate 1 ml Inj,Lorazepam 2 mg per ml 2 ml Inj,Diltiazem 5 mg per ml Inj,Levo-Salbutam

GEM
Goods
Qty:4,531
4 Files
Indian Army
Boq › Boql
Adrenaline Tartrate 1 ml Inj , Lorazepam 2 mg per ml 2 ml Inj , Diltiazem 5 mg per ml Inj , Levo-Salbutamol 1.25 mg and Ipratropium 500 mcg in 2.5 ml Respule , Labetalol HCl 5 mg per ml 4 ml Inj , Inj Thiamine 100 mg per ml 2 ml Amp , Oxytocin 5 units per 1.0 ml amp Inj , Tranexamic Acid 500 mg per 5 ml Inj , Esmolol 100 mg PER10 ml Inj , Lignocaine HCl solution 2 percent for IV use 50 ml Inj , Morphine 15 mg 1 ml Inj , Pethedine 50 mg 1 ml Inj , Tramadol HCl 50 mg per ml Inj 1 ml Amp , Dexmedetomidine 100 mcg per ml Inj , Dextrose 50 percent 25 ml Inj , Dextrose Inj 25 percent 25 ml Inj , Metoprolol 1 mg perml 5 ml Inj , Vasopressin 20 units per ml Inj 1 ml ampoule , Dopamine HCl 40 mg per ml 5 ml Inj , Dobutamine HCl 250 mg PER5 ml Inj , Noradrenaline Bitartrate 2 mg per ml 2 ml Inj , Ranitidine HCl 50 mg 2 ml Inj , Haloperidol 5 mg per ml Inj , Neostigmine 0.5 mg 1 ml Inj , Vecuronium Bromide 4 mg per ml 1 ml Inj , Atracurium 10 mg per ml 2.5 ml Inj , Diazepam 10 mg 2 ml Inj , Nitrofurantoin 100 mg Tab , Trypsin with chymotrypsin Tab , Tramadol HCl 50 mg Cap or Tab , Cilnidipine 5 mg Tab , Tofacitinib 5 mg Tab , Lorazepam 1 mg Tab , Clonazepam 0.5 mg Tab , Antispasmodic Tab containing Mefenamic Acid 250 mg and Dicyclomine HCl 10 mg , Nebivolol 5 mg, Tab , Colchicine 0.5 mg Tab , Glucosamine 500 mg Tab , Glucosamine 250 mg and Chondroitin Sulphate 200 mg Cap , Diazepam 5 mg Tab
May 1, 2025
May 22, 2025 at 12:00 PM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered legal entity with the relevant licenses for pharmaceutical manufacturing or supply. Bidders must also possess certifications that confirm compliance with health regulations and have prior experience in supplying to governmental or military sectors.

The products must meet the technical specifications outlined in the tender, which includes compliance with the Indian pharmacopoeia standards. Additionally, bidders are expected to provide verification of quality assurance protocols and other relevant quality standards.

The Earnest Money Deposit (EMD) is a financial assurance required from bidders to confirm their intention to participate in the tender. Specific details about the EMD amount and payment methods will be provided in the tender documentation.

Tender submissions must be done electronically through the specified e-tendering platform. It is essential for bidders to adhere to the format and documentation requirements as laid out in the tender to ensure successful submission.

Yes, the tender includes special provisions and incentives for Micro, Small, and Medium Enterprises (MSEs), aimed at promoting their participation in government contracts. This initiative fosters a competitive environment and supports the local economy by providing MSEs equal opportunities to participate in public procurements.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders